Cancer survivorship care encompasses a multifaceted approach that extends beyond the management of residual physical side effects from treatments such as chemotherapy, radiation, or surgery. It involves continuous surveillance for recurrence, screening for secondary malignancies, management of long-term treatment toxicities, and integration of mental health support. Given the varied nature of these needs, the delivery of surveillance and supportive care is inherently complex and demands coordinated efforts among multiple healthcare providers.

In recent exploratory research conducted by the University of Missouri School of Medicine, investigators delved into the experiences of female cancer survivors transitioning from acute oncology care to longer-term survivorship management overseen largely by primary care clinicians (PCCs). This stratified care shift aims to leverage the longitudinal and holistic relationship that primary care providers have with patients, but the study illuminated significant systemic and practical challenges impeding continuity of care. Among the 57 women surveyed and interviewed, only about one-third reported consistent contact with the same primary care clinician post-treatment, highlighting fragmentation risks.

The fragmented nature of survivorship care stems in part from unclear delineations of roles and responsibilities between oncologists and primary care practitioners. When transitioning patients after active treatment, ambiguity regarding who is accountable for surveillance protocols, symptom management, and psychological support can cause gaps in care continuity. Miscommunications between specialties and lapses in patient-provider relationships may exacerbate these discontinuities, potentially compromising early detection of recurrence or management of late effects.

Moreover, the research resonates with findings from previous studies that many primary care providers experience a lack of confidence and preparedness to deliver comprehensive survivorship care. Despite their willingness to engage in additional training, PCCs often cite insufficient educational resources and ambiguous clinical guidelines as barriers. This gap presents an opportunity for integrating targeted educational programs within primary care training frameworks to enhance preparedness for survivorship challenges.

Notably, the research team identifies several promising educational interventions designed to equip primary care clinicians with the necessary knowledge and skills. These include modular online courses, interactive workshops, webinars, and tele-mentoring programs like the Extension for Community Healthcare Outcomes (ECHO) model. The ECHO program, in particular, facilitates remote collaboration and case-based learning between oncology specialists and primary care teams, promoting shared expertise and improved patient outcomes.

The study also underscores the preference among many cancer survivors for shared-care models, where primary care and oncology specialists collaboratively engage in ongoing management. Shared-care approaches capitalize on the strengths of both disciplines: oncologists bring in-depth knowledge of cancer-specific risks and therapies, while PCCs offer longitudinal oversight of overall health, comorbidities, and preventive care. Such models can foster patient-centered continuity and potentially mitigate fragmentation.

Looking forward, the researchers aim to expand investigations into the evolving needs and preferences of cancer survivors during the survivorship phase. Understanding nuanced patient priorities—ranging from symptom management and psychosocial support to communication preferences—will be critical in designing survivorship care pathways that are not only clinically effective but also aligned with patients’ lived experiences and expectations.

This body of work contributes valuable insights into the structural and educational reforms necessary to optimize cancer survivorship care. As the survivor population grows, health systems must innovate integrated care models that adequately support primary care clinicians, promote seamless specialty-primary care coordination, and address the holistic needs of survivors.

The broader implications of these findings highlight a pressing need for policy initiatives and resource allocation to enhance survivorship training and care infrastructure. Investing in scalable educational platforms and fostering multidisciplinary collaboration will be key to meeting the anticipated demand for comprehensive survivorship services.

In sum, while advances in oncology have significantly improved survival, the continuum of care beyond treatment remains riddled with challenges. Empowering primary care providers through targeted education and structured collaborative models offers a promising avenue to bridge existing gaps. This approach is poised to redefine survivorship care and improve outcomes for millions who navigate life after cancer treatment.

The observational study titled “Continuity of Cancer Care: Female Participants’ Report of Healthcare Experiences After Conclusion of Primary Treatment” was published in the July 2025 issue of Current Oncology. Authored by experts including Jane McElroy, PhD, of the University of Missouri’s Department of Family and Community Medicine, and Mirna Becevic, PhD, from the Department of Dermatology, the study highlights essential directions for future cancer survivorship research and clinical practice.

Subject of Research: People

Article Title: Continuity of Cancer Care: Female Participants’ Report of Healthcare Experiences After Conclusion of Primary Treatment

News Publication Date: 11-Jul-2025

Web References:
DOI: 10.3390/curroncol32070399

Keywords:
Family medicine, Oncology, Cancer patients, Cancer screening, Preventive medicine, Cancer treatments

Survivorship care, a comprehensive approach designed to support patients after their primary cancer treatment concludes, remains underutilized and under-recognized, even as the population of cancer survivors continues to rise. The Northwestern study surveyed over 300 individuals treated for head-and-neck cancers over the past decade, revealing that more than 70% reported their mental health needs went unaddressed during treatment. This troubling statistic underscores a systemic blind spot within oncology care, which often prioritizes tumor surveillance and physical recovery while overlooking psychosocial well-being.

Head-and-neck cancer patients frequently endure debilitating side effects, many of which persist long after radiation therapy ends. These include xerostomia (dry mouth), dysphagia (difficulty swallowing), altered taste perception, and ongoing dental problems, all of which compromise quality of life and complicate nutrition and social interaction. Astonishingly, 40% of survey respondents continued to suffer from dry mouth, and nearly 25% reported swallowing difficulties, illustrating the chronic burdens patients carry. Despite these challenges, less than a third of these survivors had sufficient information or access to survivorship care programs designed to address such long-term effects.

This gap in care is not merely about managing physical symptoms—it extends deeply into mental health. Approximately 15% of surveyed survivors screened positive for clinical depression, a condition often masked or dismissed in oncology settings. The resilience required to navigate the aftermath of cancer treatment is formidable, and psychological distress can exacerbate physical symptoms, impede recovery, and diminish overall well-being. The failure to integrate mental health services as a standard component of cancer follow-up care reveals a critical insufficiency in patient-centered oncology.

Traditional oncology follow-ups tend to focus narrowly on detecting cancer recurrence, but longer-living survivors necessitate a broader framework that encompasses chronic disease management, preventive health, and psychosocial support. The researchers at Northwestern advocate for adopting the Cancer Survivorship Framework—a multidisciplinary model addressing five essential domains: physical effects, psychosocial health, cancer screening, chronic disease management, and health promotion. This holistic approach aims to deliver personalized care that adapts to survivors’ evolving needs over time, and it has the potential to be applied widely across cancer types beyond head-and-neck malignancies.

Interestingly, the study also discovered that nearly half of surveyed patients preferred a survivorship care model involving one extended clinic visit every six to twelve months, as opposed to multiple shorter appointments. This preference highlights a need for coordinated, efficient care pathways that can comprehensively evaluate patients’ multifaceted needs in a single setting. Women and those recently completing treatment expressed stronger preferences for this model, suggesting that timing and demographic factors influence care delivery preferences which healthcare systems should carefully consider.

Addressing these complex needs requires assembling dedicated, multidisciplinary teams composed not only of oncologists but also dietitians, mental health counselors, social workers, and other specialists. This integrated model would empower patients with tailored interventions targeting both the physical and emotional challenges of cancer survivorship. Alexis Larson, the study’s lead author and a certified nurse practitioner at Northwestern Medicine, emphasizes that comprehensive survivorship care cannot be relegated to brief encounters but must be thoughtfully constructed to provide sustained and coordinated support.

The urgency of this need is underscored by demographic trends: in 2022, there were an estimated 18.1 million cancer survivors in the United States alone, accounting for roughly 5.4% of the population. Projections indicate this number will swell to 26 million by 2040 due to advances in therapeutic approaches and an aging society. This burgeoning survivor cohort demands scalable, systematic approaches to survivorship that ensure patients are not left isolated after treatment completion.

Taking these findings into practice, Northwestern Medicine is pioneering a dedicated survivorship clinic embedded within its Department of Radiation Oncology. Building on insights from the study, the clinic will incorporate all five domains of the Cancer Survivorship Framework and specifically focus on integrating mental health resources, including pilot testing cognitive behavioral therapy (CBT) interventions. This targeted approach aims to mitigate psychological distress and help patients manage chronic pain, anxiety, and depression that frequently accompany post-radiation recovery.

Moreover, this initiative will complement existing survivorship programs available through the Robert H. Lurie Comprehensive Cancer Center but distinguishes itself by delivering care within the very environment where patients received their initial treatment. Such proximity facilitates continuity, enhances communication between care teams and patients, and fosters more seamless coordination of services. It represents a strategic step toward patient-centered care innovations that resonate with survivors’ articulated needs.

Published in the journal Supportive Care in Cancer on April 30, 2025, the study titled “Survivorship Therapy Needs after Radiotherapy for Head and Neck Cancer: Surveying Opportunities for Growth (STRONG)” spotlights the profound importance of rethinking survivorship paradigms. Funded partly by the National Institutes of Health’s National Center for Advancing Translational Sciences, this research offers a compelling call to action for clinicians, healthcare systems, and policymakers to prioritize comprehensive survivorship services that holistically address both the seen and unseen consequences of cancer treatment.

As oncology continuously evolves, it is imperative that survivorship care keeps pace, embracing the complex intersection of physical symptoms, mental health, and long-term wellness. By integrating multidisciplinary care models and embedding validated psychological interventions within survivorship programs, institutions like Northwestern Medicine are charting a path forward. This approach transcends head-and-neck cancer and offers an adaptable template for all cancer survivors, ensuring that the triumphs of extended survival are matched by improved quality of life.

History has shown that curing cancer is only half the battle—the true victory lies in supporting survivors to thrive beyond their diagnosis. Studies like STRONG underscore that survivorship care is not a luxury but a necessity, demanding renewed focus and resources as the cancer survivor population expands. It is time for oncology practices across the globe to heed these findings and foster a healthcare ecosystem equipped to heal the whole person, body and mind.

Subject of Research: Survivorship care needs and mental health support in head-and-neck cancer survivors post-radiotherapy.

Article Title: Survivorship Therapy needs after Radiotherapy for head and Neck cancer: surveying opportunities for Growth (STRONG)

News Publication Date: 30-Apr-2025

Web References:

• Journal article DOI: 10.1007/s00520-025-09429-2
• Cancer Survivorship Framework: https://pmc.ncbi.nlm.nih.gov/articles/PMC6855988/

References: Northwestern Medicine study conducted on 317 head and neck cancer survivors between 2013 and 2023; published in Supportive Care in Cancer, April 2025.

Keywords: Cancer, Radiation therapy, Cancer patients, Head and neck cancer, Cancer screening, Cancer policy